Sign In
Buy ATHX
$0.0135
+0 (+0%)
At Close: Apr 05, 2024
Why Celyad Oncology Is Trading Higher By Over 31%; Here Are 29 Stocks Moving Premarket
10:43am, Monday, 01'st Aug 2022 Benzinga
Gainers
MAIA Biotechnology, Inc. (NASDAQ: MAIA) rose 37.9% to $8.00 in pre-market trading after jumping 30% on Friday. The company agreed to initially offer 2.00 million shares to the public at a $5.
This Communication Services Stock Jumped 149%; Here Are 90 Biggest Movers From Friday
09:27am, Monday, 01'st Aug 2022 Benzinga
Gainers
Getty Images Holdings, Inc. (NYSE: GETY) shares climbed 149.1% to close at $26.15 on Friday following its merger with special-purpose acquisition company (SPAC) CC Neuberger Principal Holdin
Why Lottery.com Shares Are Trading Lower By 59%? 54 Stocks Moving In Friday's Mid-Day Session
05:05pm, Friday, 29'th Jul 2022 Benzinga
Gainers
Getty Images Holdings, Inc. (NYSE: GETY) shares jumped 106.7% to $21.69 after nearly 99.4% of shares were redeemed by CCNB shareholders.
NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) rose 91.1% t
This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday
09:55am, Friday, 29'th Jul 2022 Benzinga
Gainers
Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11, 20
Why Shares of Solar Companies Are Trading Higher? 64 Stocks Moving In Thursday's Mid-Day Session
04:41pm, Thursday, 28'th Jul 2022 Benzinga
Gainers
Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) gained 231% to $2.63 on news that the company will be acquired By Henry Crown and Company for $3.25 per share. Petros Pharmaceuticals, however, con
Best Penny Stocks To Buy As Recession Begins? 5 Biotech Stocks To Watch
03:30pm, Thursday, 28'th Jul 2022 PennyStocks
Biotech penny stocks to watch this week.
The post Best Penny Stocks To Buy As Recession Begins? 5 Biotech Stocks To Watch appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStoc
Best Penny Stocks To Buy As Recession Begins? 5 Biotech Stocks To Watch
11:30am, Thursday, 28'th Jul 2022
Biotech penny stocks to watch this week. The post Best Penny Stocks To Buy As Recession Begins?
Why Meta Platforms Is Trading Lower By More Than 6%: Here Are 34 Stocks Moving Premarket
10:09am, Thursday, 28'th Jul 2022 Benzinga
Gainers
JAKKS Pacific, Inc. (NASDAQ: JAKK) rose 34.7% to $23.01 in pre-market trading after the company reported better-than-expected Q2 results.
Athersys, Inc. (NASDAQ: ATHX) rose 35.1% to $0.2568 i
This Healthcare Stock Surges Around 115%, Here's 74 Biggest Movers From Yesterday
08:55am, Thursday, 30'th Jun 2022 Benzinga
Gainers
Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) shares surged 114.3% to close at $0.2550 on Wednesday after the company announced it has terminated its previously announced at-the-market offerin
Why Is Allena Pharmaceuticals Jumping By 207%? 45 Stocks Moving In Wednesday's Mid-Day Session
04:32pm, Wednesday, 29'th Jun 2022 Benzinga
Gainers
Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 207% to $0.3650 after the company announced it has terminated its previously announced at-the-market offering.
Brickell Biotech, Inc. (NASD
Top Penny Stocks To Buy For Under $1? 3 To Watch This Week
04:41pm, Monday, 06'th Jun 2022 PennyStocks
Stocks Under $1 To Watch This Week.
The post Top Penny Stocks To Buy For Under $1? 3 To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Top Penny Stocks To Buy For Under $1? 3 To Watch This Week
12:41pm, Monday, 06'th Jun 2022
Stocks Under $1 To Watch This Week. The post Top Penny Stocks To Buy For Under $1?
Athersys (ATHX) Down as Ischemic Stroke Study Fails to Meet Goal
07:32pm, Monday, 23'rd May 2022 Zacks Investment Research
While a mid-stage/late-stage study evaluating Athersys' (ATHX) stem cell treatment for ischemic stroke misses out on its primary endpoint, top-line data shows evidence of therapeutic impact.
Athersys (ATHX) Down as Ischemic Stroke Study Fails to Meet Goal
04:34pm, Monday, 23'rd May 2022
While a mid-stage/late-stage study evaluating Athersys' (ATHX) stem cell treatment for ischemic stroke misses out on its primary endpoint, top-line data shows evidence of therapeutic impact.
Athersys-Partnered Japanese Ischemic Stroke Study Disappoints, Shares Plunge
10:38am, Friday, 20'th May 2022
Athersys Inc's (NASDAQ: ATHX) partner, Healios K.K. has reported topline results for its Japan ischemic stroke study, TREASURE.
